Michael Econs, M.D.
Indiana University School of Medicine, USA
John Eisman, MBBS, Ph.D.
Garvan Institute of Medical Research, Australia
Hypophosphatasia: Bone-Targeted Enzyme-Replacement Therapy
Michael Whyte, M.D.
Shriners Hospital for Children-Saint Louis, USA
Prospects for FGF-23 Antibody Therapy
Seiji Fukumoto, M.D., Ph.D.
University of Tokyo Hospital, Japan
Osteoporosis, Cathepsin K Enzyme Inhibition
Bente Langdahl, M.D., DMSc
Aarhus University Hospital, Denmark
Supported by educational grants from Lilly USA, LLC and Merck & Co., Inc.
Length: 75 minutes